Dr. Reddy’s is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy’s also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy’s has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy’s also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
Company address
8-2-337, Road No. 3, Banjara Hills, Hyderabad, TG, 500
Kuvera gives you rich data insights and peer comparison for informed stock investment decisions. Just import your stock portfolio from your broking platform to Kuvera to track your investments and place your buy / sell orders.
1. Login to the Kuvera app or website and go to Invest section.
2. Select stocks and search for Dr Reddy's Laboratories Ltd or scroll over to Dr Reddy's Laboratories Ltd
3. Once you have understood its performance and financials, tap on Buy. You will be taken to your existing brokerage account for completing the transaction.
What is the Share Price of Dr Reddy's Laboratories Ltd?
The share price of Dr Reddy's Laboratories Ltd stocks is ₹1,189.45 as on 18/11/2024
What is the Market Cap of Dr Reddy's Laboratories Ltd?
Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Dr Reddy's Laboratories Ltd stock is ₹19,824.5 Cr on 18/11/2024.
In which sector / industry does Dr Reddy's Laboratories Ltd operate?
Dr Reddy's Laboratories Ltd operates in Healthcare / Drug Manufacturers - Specialty & Generic.
What was the revenue of Dr Reddy's Laboratories Ltd?
The revenue of Dr Reddy's Laboratories Ltd as of 2023 was ₹27,916.4 Cr
What is the PE ratio of Dr Reddy's Laboratories Ltd?
The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its
current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is
overvalued in relation to the earnings (revenue) generated. P/E ratio of Dr Reddy's Laboratories Ltd is
3.57 as on 18/11/2024.
What is the 52 week high price of Dr Reddy's Laboratories Ltd?
The 52 week high of Dr Reddy's Laboratories Ltd stock is ₹1,420.20.
What is the 52 week low price of Dr Reddy's Laboratories Ltd?
The 52 week low of Dr Reddy's Laboratories Ltd stock is ₹1,074.35.
Can fractional shares of Dr Reddy's Laboratories Ltd be purchased?
No, you cannot buy fractional shares of Dr Reddy's Laboratories Ltd, or any listed Indian company as of now.